FOLH1 and xerostomia: Monoclonal antibodies like J591 have unique benefits, including lower salivary gland toxicity and reduced renal toxicity, as their larger size prevents renal and salivary gland penetration and common side effects like xerostomia, which is prevalent with small molecule ligands like PSMA-617 [90].